Caspase activation is required for terminal erythroid differentiation

J Exp Med. 2001 Jan 15;193(2):247-54. doi: 10.1084/jem.193.2.247.

Abstract

The cysteine proteases known as caspases play a central role in most apoptotic pathways. Here, we show that caspase inhibitors arrest the maturation of human erythroid progenitors at early stages of differentiation, before nucleus and chromatin condensation. Effector caspases such as caspase-3 are transiently activated through the mitochondrial pathway during erythroblast differentiation and cleave proteins involved in nucleus integrity (lamin B) and chromatin condensation (acinus)without inducing cell death and cleavage of GATA-1. These observations indicate a new function for caspases as key proteases in the process of erythroid differentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Caspase Inhibitors
  • Caspases / metabolism*
  • Cell Differentiation / drug effects
  • Cysteine Proteinase Inhibitors / pharmacology
  • Enzyme Activation
  • Erythroblasts / cytology
  • Erythroblasts / drug effects
  • Erythroblasts / enzymology
  • Erythrocytes / cytology
  • Erythrocytes / drug effects
  • Erythrocytes / enzymology*
  • Erythropoiesis / drug effects
  • Erythropoiesis / physiology*
  • Humans
  • In Vitro Techniques
  • Membrane Potentials / drug effects

Substances

  • Amino Acid Chloromethyl Ketones
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • Caspases